BMY vs ETR · P/E 17, rev $48.19B vs P/E 28, rev $12.95B
Bristol-Myers Squibb Company (BMY) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the BMY and ETR stock pages for the full models.
Not investment advice.